SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-042606
Filing Date
2019-11-12
Accepted
2019-11-12 08:15:24
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q scyx-10q_20190930.htm 10-Q 1967207
2 EX-31.1 scyx-ex311_7.htm EX-31.1 15632
3 EX-31.2 scyx-ex312_6.htm EX-31.2 15597
4 EX-32.1 scyx-ex321_9.htm EX-32.1 9425
  Complete submission text file 0001564590-19-042606.txt   9370899

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT scyx-20190930.xml EX-101.INS 2741319
6 XBRL TAXONOMY EXTENSION SCHEMA scyx-20190930.xsd EX-101.SCH 45070
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE scyx-20190930_cal.xml EX-101.CAL 55189
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE scyx-20190930_def.xml EX-101.DEF 149112
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE scyx-20190930_lab.xml EX-101.LAB 411818
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE scyx-20190930_pre.xml EX-101.PRE 320681
Mailing Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548
Business Address 1 EVERTRUST PLAZA 13TH FLOOR JERSEY CITY NJ 07302-6548 201-884-5485
SCYNEXIS INC (Filer) CIK: 0001178253 (see all company filings)

IRS No.: 562181648 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36365 | Film No.: 191206297
SIC: 2834 Pharmaceutical Preparations